Frederick L. Altice, M.D., is a Professor of Medicine and Professor of Epidemiology and Public Health at Yale University School of Medicine. He is the Director of Clinical and Community Research, where he also directs the Community Health Care Van and the HIV in Prisons Program.
Dr. Altice’s research interests are focused on the interface of infectious diseases, including HIV, tuberculosis and viral hepatitis, and substance use disorders. Specifically, he is interested in prevention, treatment and behavioral intervention research activities. As a clinical epidemiologist and intervention researcher, he has created novel programs for the treatment of HIV, viral hepatitis, tuberculosis, and substance use disorders in vulnerable populations, including injection drug users, criminal justice populations, and men who have sex with men. In addition to developing protocols to directly administer antiretroviral therapy to improve adherence among HIV-infected drug users and released prisoners, Dr. Altice has been at the forefront of integrating medication-assisted therapies such as methadone, buprenorphine and extended-release naltrexone into treatments for individuals with HIV, HCV, tuberculosis, and mental illness.
Dr. Altice is currently principal investigator on numerous clinical investigations funded by the National Institutes on Health and several other federal agencies and served as a leading member of the World Health Organization’s Policy Guidelines For Collaborative Tuberculosis And HIV Services For Injecting and Other Drug Users: An Integrated Approach. Dr. Altice is currently leading studies in Ukraine, Russia, Central Asia, Malaysia, Peru, and the United States. In addition to publishing his research in peer-reviewed journals, Dr. Altice has authored several significant books and book chapters. He lectures nationally and internationally on the subject of HIV, viral hepatitis, TB, substance abuse and the delivery and organization of healthcare services, including integrated healthcare.